Company news

In January 2018, PrJSC "INDAR" successfully passed an on-site inspection for the compliance of insulin medications with the international standards of Good Manufacturing Practice (GMP), as it was reported in the official journal of the federal government of Brazil (Diário Oficial da União).

On November 28th-29th, 2017 PrJSC «INDAR» became a participant of the international pharmaceutical industry event in the South African region called SAPHEX. The exhibition SAPHEX-2017 was held at Sandton Convention Center (Johannesburg, Gauteng, South Africa).

It’s become a good tradition for PrJSC “INDAR” to represent the products over the world.
On October 24-26, 2017, the enterprise participated in the main event of pharmaceutical global industry – International Specialized Exhibition CPhI Worldwide-2017, which took place in Germany (Frankfurt).

PrJsC "Indar" in cooperation with the Swiss company, have developed new pen injector for insulin id Pen, which is characterized by high accuracy and ease of use.

2000 of Ukrainians had an opportunity to check their blood sugar level for free within a special action dedicated to the World Diabetes Day.

PJSC Indar (Kyiv), the only Ukrainian company with a full cycle of insulin production, plans in 2014 to begin insulin production in Brazil at a plant built with the technology of Indar.

"In 2014, we are to start insulin production in Brazil at the "in bulk" stage. By the end of 2015, we have to finish the construction of a plant for bottling insulin, and in 2016 Brazil will have insulin production with a complete cycle," Indar Board Chairman Liubov Vyshnevska told Interfax- Ukraine.